Introduction: Despite numerous reports on pregnancy outcomes after trachelectomy, there are few descriptions of fertility treatment after trachelectomy. Moreover, little is known about the differences in fertility outcomes between various radical trachelectomy procedures. The purpose of this report was to clarify the infertility problems that occur in patients who have previously undergone an abdominal trachelectomy.
Material And Methods: We retrospectively investigated the medical records of 37 patients who received fertility treatments or were evaluated for menstrual disorders after trachelectomies in our institution between 2012 and 2016.
Results: Twenty-two of 37 patients had complications which affected fecundity. Six patients had cervical stenosis requiring surgical dilation, 4 had ovarian insufficiency, and 14 had Asherman's syndrome.
Conclusions: In spite of efforts to preserve fertility, some patients have severe complications after trachelectomy, such as Asherman's syndrome, resulting in infertility. Clinicians should pay careful attention to the status of the endometrial cavity after trachelectomy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/aogs.13429 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Modified abdominal radical trachelectomy used to spare fertility during surgery for early-stage cervical cancer: a case report.
J Med Case Rep
November 2024
Tu Du Clinical Research Unit (TD-CRU), Tu Du Hospital, Ho Chi Minh City, Vietnam.
Background: Cervical cancer is the fourth most common malignant tumor in childbearing-age women. To date, cervical resection and fertility-sparing surgery are the trends in the era of minimally invasive management. However, a proper management remains crucial.
View Article and Find Full Text PDFLaparoscopic Robotic Assisted Surgery in Reproductive Medicine.
Arch Med Res
December 2024
Department of Obstetrics and Gynecology, Southern Illinois University, Springfield, Illinois, USA. Electronic address:
Article Synopsis
- Laparoscopic Robot-assisted surgery is a cutting-edge advancement in surgical technology, particularly benefiting reproductive medicine by enhancing fertility and providing innovative treatment options for gynecological conditions.
- Compared to traditional open surgery, it offers reduced post-surgical hospital stays and blood loss, with mixed results on operative times due to varying surgeon experience.
- Despite challenges like high costs and lack of tactile feedback, recent improvements—including the integration of Artificial Intelligence—are enhancing its applications for fertility preservation in female cancer survivors and other reproductive surgeries.
Successful Outcome of Stage IB3 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Vaginal Radical Trachelectomy: A Case Report.
Cureus
October 2024
Obstetrics and Gynecology, Sapporo Medical University, Sapporo, JPN.
Vaginal trachelectomy, which involves resecting the cervix and its parametrium, is a fertility-sparing option for the treatment of early-stage cervical cancer. Although no consensus has been reached on whether simple or radical trachelectomy is preferable, the vaginal approach is typically avoided for tumors larger than 2 cm due to concerns about recurrence. However, some evidence suggests that fertility preservation may still be viable for select patients with larger tumors.
View Article and Find Full Text PDFFirst robotic radical trachelectomy for cervical cancer using the Hugo RAS platform.
Int J Gynecol Cancer
January 2025
Gynecology Oncology Department, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Reproductive, obstetrical and oncological outcomes of fertility-sparing treatment for cervical cancer according to the FIGO 2018 staging system: A systematic review.
Eur J Surg Oncol
January 2025
Department of Maternal and Child Health, Obstetrics and Gynecology Clinic, Ospedale Santa Maria della Misericordia, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy; PhD School in Biomedical Sciences, Gender Medicine, Child and Women Health, University of Sassari, Sassari, Italy.
Objective: We assessed reproductive, obstetrical, and oncological outcomes in patients who underwent fertility-sparing treatment by including studies that adhere to the FIGO 2018 staging system.
Methods: Data on recurrence, mortality, pregnancy rate, live birth rate, and preterm delivery rate were collected.
Results: In patients with stages IA1, IA2, and IB1, the recurrence rate was 4.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!